Clinical trials
Observational Emphysema trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2004 | 3 |
| 2006 | 3 |
| 2007 | 7 |
| 2009 | 5 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 4 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
| Recruiting | 8 |
| Active, not recruiting | 3 |
| Terminated | 2 |
| Unknown status | 2 |
| Enrolling by invitation | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Pittsburgh | 6 |
| Washington University School of Medicine | 4 |
| Weill Medical College of Cornell University | 4 |
| Columbia University | 3 |
| Brigham and Women's Hospital | 2 |
| Gelb, Arthur F., M.D. | 2 |
| Temple University | 2 |
| Adverum Biotechnologies, Inc. | 1 |
| COPD Foundation | 1 |
| Colorado State University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Emphysema | 46 |
| Pulmonary Disease, Chronic Obstructive | 37 |
| Bronchitis, Chronic | 11 |
| Lung Diseases | 7 |
| HIV Infections | 5 |
| Asthma | 4 |
| Bronchitis | 4 |
| alpha 1-Antitrypsin Deficiency | 4 |
| Inflammation | 2 |
| Lung Neoplasms | 2 |
Trials
Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.